[go: up one dir, main page]

IL159219A0 - Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL159219A0
IL159219A0 IL15921902A IL15921902A IL159219A0 IL 159219 A0 IL159219 A0 IL 159219A0 IL 15921902 A IL15921902 A IL 15921902A IL 15921902 A IL15921902 A IL 15921902A IL 159219 A0 IL159219 A0 IL 159219A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
oxadiazole derivatives
pyrrolidine oxadiazole
Prior art date
Application number
IL15921902A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL159219A0 publication Critical patent/IL159219A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL15921902A 2001-06-18 2002-06-14 Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them IL159219A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18
PCT/EP2002/006629 WO2002102799A2 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists

Publications (1)

Publication Number Publication Date
IL159219A0 true IL159219A0 (en) 2004-06-01

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15921902A IL159219A0 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (2) US7115639B2 (xx)
EP (1) EP1444225B1 (xx)
JP (1) JP4426284B2 (xx)
KR (1) KR20040030678A (xx)
CN (1) CN100564378C (xx)
AR (1) AR036108A1 (xx)
AU (1) AU2002319237B2 (xx)
BG (1) BG108424A (xx)
BR (1) BR0211030A (xx)
CA (1) CA2449578C (xx)
CZ (1) CZ20033475A3 (xx)
EA (1) EA006212B1 (xx)
EE (1) EE200400022A (xx)
ES (1) ES2397305T3 (xx)
HK (1) HK1074204A1 (xx)
HR (1) HRP20031017A2 (xx)
HU (1) HUP0400238A2 (xx)
IL (1) IL159219A0 (xx)
MX (1) MXPA03011441A (xx)
MY (1) MY128890A (xx)
NO (1) NO20035399L (xx)
PL (1) PL367275A1 (xx)
RS (1) RS99503A (xx)
SK (1) SK15552003A3 (xx)
UA (1) UA75145C2 (xx)
WO (1) WO2002102799A2 (xx)
ZA (1) ZA200309402B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002319237B2 (en) 2001-06-18 2008-01-03 Merck Serono Sa Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists
CA2515546C (en) 2003-02-27 2011-11-22 Applied Research Systems Ars Holding N.V. Pyrrolidine derivatives as oxytocin antagonists
DK1725526T3 (da) * 2004-02-26 2008-03-03 Serono Lab Fremgangsmåde til fremstilling af pyrrolidinoximer
BR122020016659B8 (pt) 2005-05-10 2021-07-27 Incyte Holdings Corp moduladores de 2,3-dioxigenase de indolamina e métodos de modulação de atividade de inibição e de imunossupressão
JP5294874B2 (ja) 2005-12-20 2013-09-18 インサイト・コーポレイション インドールアミン２，３−ジオキシゲナーゼのモジュレーターとしてのｎ−ヒドロキシアミジノヘテロ環
ES2444574T3 (es) 2006-09-19 2014-02-25 Incyte Corporation N-hidroxiamidinoheterociclos como moduladores de la indolamina 2,3-dioxigenasa
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
LT2824100T (lt) 2008-07-08 2018-05-10 Incyte Holdings Corporation 1,2,5-oksadiazolai, kaip indolamino 2,3-dioksigenazės inhibitoriai
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
LT3066085T (lt) 2013-11-08 2020-06-25 Incyte Holdings Corporation Indolamino 2,3-dioksigenazės inhibitoriaus sintezės būdas
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
CN106795110A (zh) 2014-07-02 2017-05-31 奥布赛瓦股份公司 治疗ot‑r活性相关的病症的方法中可用的晶体(3z，5s)‑5‑(羟甲基)‑1‑[(2’‑甲基‑1，1’‑联苯‑4‑基)羰基]吡咯烷‑3‑酮o‑甲基肟

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
CA2210138A1 (en) 1995-01-24 1996-08-01 Peter D. Williams Tocolytic oxytocin receptor antagonists
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) * 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
DE60026514T2 (de) 1999-05-05 2006-11-09 Merck & Co., Inc. Neue prolinverbindungen als mikrobizide mittel
ES2262640T3 (es) 2000-03-27 2006-12-01 Applied Research Systems Ars Holding N.V. Derivados de pirrolidina farmaceuticamente activos como inhibidores de bax.
DK1268419T3 (da) * 2000-03-27 2006-10-02 Applied Research Systems Farmaceutisk aktive pyrrolidinderivater som BAX-inhibitorer
WO2002032864A1 (en) * 2000-10-17 2002-04-25 Applied Research Systems Ars Holding N.V. Pharmaceutically active sulfanilide derivatives
JP4350948B2 (ja) * 2001-03-20 2009-10-28 ラボラトワール セローノ ソシエテ アノニム オキシトシン調節活性を有するピロリジンエステル誘導体
AU2002319237B2 (en) 2001-06-18 2008-01-03 Merck Serono Sa Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists
DE60207755T2 (de) * 2001-12-20 2006-07-27 Applied Research Systems Ars Holding N.V. Triazole als oxytocin-antagonisten
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
CA2449578A1 (en) 2002-12-27
NO20035399L (no) 2004-02-17
ES2397305T3 (es) 2013-03-06
WO2002102799A2 (en) 2002-12-27
MXPA03011441A (es) 2004-07-01
AR036108A1 (es) 2004-08-11
JP4426284B2 (ja) 2010-03-03
EA200400049A1 (ru) 2004-08-26
HK1074204A1 (en) 2005-11-04
HRP20031017A2 (en) 2004-04-30
RS99503A (xx) 2006-12-15
US20040220238A1 (en) 2004-11-04
BR0211030A (pt) 2004-06-22
EP1444225A2 (en) 2004-08-11
NO20035399D0 (no) 2003-12-04
KR20040030678A (ko) 2004-04-09
CA2449578C (en) 2011-12-13
BG108424A (en) 2005-03-31
US20060229343A1 (en) 2006-10-12
WO2002102799A3 (en) 2003-04-03
MY128890A (en) 2007-02-28
CN100564378C (zh) 2009-12-02
EA006212B1 (ru) 2005-10-27
JP2004534804A (ja) 2004-11-18
US7115639B2 (en) 2006-10-03
SK15552003A3 (sk) 2004-05-04
EE200400022A (et) 2004-04-15
CZ20033475A3 (en) 2004-05-12
AU2002319237B2 (en) 2008-01-03
UA75145C2 (en) 2006-03-15
PL367275A1 (en) 2005-02-21
EP1444225B1 (en) 2012-10-10
ZA200309402B (en) 2004-12-03
CN1639155A (zh) 2005-07-13
HUP0400238A2 (hu) 2004-07-28

Similar Documents

Publication Publication Date Title
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
IL151209A0 (en) Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
HUP0400636A3 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0400451A3 (en) Pyrrole derivatives and pharmaceutical compositions containing them
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
IL154965A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
HUP0400156A3 (en) Pyrrolidine derivatives as factor xa inhibitors, their preparation and pharmaceutical compositions containing them
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
IL154966A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0400154A3 (en) Heterocondesated benzoxazepine and benzoxathiazepine derivatives, their use and pharmaceutical compositions containing them
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HK1052168A1 (en) N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them.
SI1245565T1 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402600A3 (en) D-proline derivatives and pharmaceutical compositions containing them